TL;DR
Get workout gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Cellino has launched Reservoir, a service for adults to bank immune cells collected through a blood draw and stored at very low temperatures. Pricing typically starts at about $5,000, including the first year of storage, with a $270 annual fee afterward; whether the cells will provide health benefits or have useful future applications is not established.
Biotech company Cellino has launched Reservoir, a service that lets adults bank immune cells collected through a standard blood draw, for a typical starting price of about $5,000. The company says the cells are cryopreserved for potential future medical use, but no specific future treatment or health benefit has been established for consumers who store them.
Reservoir collects peripheral blood mononuclear cells (PBMCs), a group that includes T cells, B cells, natural killer cells and monocytes. The process begins at a partner clinic or, in select markets, through an at-home appointment. Cellino says the sample is processed, counted and stored below -150°C in an FDA-registered facility, with tracking records maintained under the member’s name.
The service typically costs about $5,000, varying by clinic, and the price includes collection, processing, cryopreservation and the first year of storage. The company lists an annual storage charge of $270 after the first year. Cellino says members own their stored cells, which are released only at their request and in coordination with a licensed physician.
Reservoir is available to adults 18 and older through partner clinics in markets including San Francisco, Los Angeles, New York and Boston. At-home collection is offered in select locations, and the company says more markets are planned. The service’s launch expands Cellino’s work from developing cell-therapy manufacturing technology into a consumer-facing preservation offering.
A Costly Bet on Future Cell Therapies
Reservoir brings a specialized biotechnology service into the consumer longevity market, where customers are increasingly offered ways to monitor or plan for future health. Unlike a test that reports a current measurement, the service is intended to preserve a person’s cells as they are at collection. That may appeal to consumers who want to retain options as cell-based medicine develops.
However, paying for storage is not the same as securing a future treatment. The clinical value of banking immune cells in advance for otherwise healthy adults remains uncertain, and the source report does not identify an approved treatment that Reservoir members can expect to access using their stored samples. The initial price and continuing storage fees make that uncertainty relevant to anyone weighing the service against other health or financial priorities.
Harvard Medical School faculty member Jay Luthar, whose clinic is a Reservoir partner, characterized the proposition as preserving optionality rather than providing a proven longevity intervention. That distinction is central: the service offers storage today, while any future medical use depends on scientific and clinical developments that have not been specified.
As an affiliate, we earn on qualifying purchases.
From Cellino’s Lab to Consumers
Cellino, based in Cambridge, Massachusetts, was co-founded in 2017 by Nabiha Saklayen and Marinna Madrid after their research at Harvard. The company is developing autonomous manufacturing technology intended to support production of personalized cell therapies. The source report says Cellino has raised more than $96 million from investors, received an award of up to $25 million from ARPA-H and earned an FDA Advanced Manufacturing Technology designation for its manufacturing platform. Those developments relate to Cellino’s broader technology work; they do not establish the effectiveness of Reservoir or guarantee future uses for stored cells.
Saklayen told Athletech News that people who learned about Cellino’s work repeatedly asked whether they could preserve their own cells. The company developed Reservoir in response to that interest. Cellino compares the service with egg freezing and cord blood banking, but the report says the potential future uses for stored immune cells are less clearly defined.
Cryopreservation is used in medical and research settings, but Reservoir’s consumer proposition is distinct: adults pay to store cells before a specific need or treatment has been identified. The source report frames the service as preservation, not as a treatment or a demonstrated way to extend lifespan.
““Cell preservation is unique because it is fundamentally about optionality: preserving your cells as they are today, so that whatever the science makes possible later, you still have the material to use.””
— Jay Luthar, Harvard Medical School faculty member and founder of Reservoir partner clinic Lutanen Health
cryopreservation blood collection kit
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Future Uses Remain Undefined
The service’s future medical applications are not specified in the source report. It does not say which therapies, if any, might use a member’s stored cells, when those treatments could become available, or what additional procedures or costs might be required. Nor does it establish that banking cells now improves health outcomes or extends life.
Cellino describes the cells as carefully processed and stored in an FDA-registered facility, but the report does not provide independent outcome data on long-term storage, cell recovery or treatment success. The FDA designation cited for Cellino concerns its manufacturing platform; it should not be read as proof that Reservoir is an approved longevity treatment. The company’s ownership and release terms are described in its statements, while full contract details and policies for circumstances such as a change in provider are not given in the report.
As an affiliate, we earn on qualifying purchases.
Expansion Depends on Local Access
Cellino says it plans to add markets beyond the initial clinic locations and is offering a nationwide waitlist. Consumers can check availability through Reservoir’s website, according to the report. The company has not provided a timeline for additional locations or said how quickly the service will expand.
For prospective customers, the immediate next steps are to confirm local pricing and collection options with a partner clinic and review the service terms, including annual fees and how stored cells may be released. Any future clinical value will depend on developments in cell-based medicine; Cellino has not announced a specific treatment timeline for Reservoir members.
As an affiliate, we earn on qualifying purchases.
Key Questions
What does Cellino’s Reservoir service do?
Reservoir collects immune cells from a blood sample, processes them and cryopreserves them for possible future medical use. Cellino says the cells are stored below -150°C.
How much does immune cell banking cost?
The service typically starts at about $5,000, though prices vary by clinic. That amount covers collection, processing, storage and the first year; Cellino lists an annual storage fee of $270 afterward.
Are the stored cells proven to improve longevity?
No such benefit is established in the source report. Cellino presents banking as a way to preserve cells for potential future use, and a Reservoir partner describes it as preserving optionality rather than a proven longevity intervention.
Who can sign up, and where is Reservoir available?
The service is for adults aged 18 and older. The report lists partner clinics in San Francisco, Los Angeles, New York and Boston, with at-home collection available in select locations and additional markets planned.
Who controls access to a member’s cells?
Cellino says members own their stored cells and that cells are released only at the member’s request in coordination with a licensed physician. The source report does not detail every contractual condition or future-use requirement.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
